Jean-Pierre Garnier
Vorsitzender bei CELLECTIS S.A.
Vermögen: 1 Mio $ am 31.10.2024
Profil
Jean-Pierre Garnier ist ein französischer Geschäftsmann, der an der Spitze von 14 verschiedenen Unternehmen stand und derzeit die Position des Non-Executive Chairman von Cellectis SA und des Chairman für Carmat SA innehat. Dr. Garnier ist außerdem Mitglied des Vorstands von Radius Health, Inc. und des Max-Planck-Instituts für biophysikalische Chemie sowie von Carrier Global Corp. und Operating Partner bei Advent International LLC. Zuvor war er Chairman bei NormOxys, Inc. und Chairman bei Alzheon, Inc. sowie Chairman von ABIONYX Pharma SA und Chairman von Cerenis Therapeutics, Inc. (eine Tochtergesellschaft von ABIONYX Pharma SA), Chairman von Idorsia Ltd., Chairman von Idorsia Pharmaceuticals Ltd., Chief Executive Officer von GlaxoSmithKline Plc und Chief Executive Officer von Smithkline Beecham Plc (eine Tochtergesellschaft von GlaxoSmithKline Plc), President von e.Nvizion Communications Group Ltd., Director von Actelion Ltd., Chief Executive Officer von Pierre Fabre SA, President von Schering-Plough Corp. und Advisor von Quaker Partners Management LP. Dr. Garnier erwarb einen MBA an der Stanford University sowie einen Doktortitel und einen Hochschulabschluss an der Louis Pasteur University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
CARRIER GLOBAL CORP.
0,00% | 18.04.2024 | 18 110 ( 0,00% ) | 1 Mio $ | 31.10.2024 |
CELLECTIS SA
-.--% | 14.02.2024 | 0 ( -.--% ) | - $ | 31.10.2024 |
BIOAGE LABS, INC.
-.--% | 25.09.2024 | 0 ( -.--% ) | - $ | 31.10.2024 |
Aktuelle Nachrichten zu Jean-Pierre Garnier
Aktive Positionen von Jean-Pierre Garnier
Unternehmen | Position | Beginn |
---|---|---|
CARRIER GLOBAL CORPORATION | Direktor/Vorstandsmitglied | 03.04.2020 |
CELLECTIS S.A. | Vorsitzender | 05.11.2020 |
BIOAGE LABS, INC. | Vorsitzender | 20.08.2024 |
Carrier Corp.
Carrier Corp. Industrial MachineryProducer Manufacturing Carrier Corp. manufactures air conditioning, heating, and refrigeration equipment. Its products include residential systems, commercial systems, transport refrigeration, and commercial refrigeration. The company was founded by Willis Haviland Carrier on July 17, 1902 and is headquartered in Jupiter, FL. | Direktor/Vorstandsmitglied | - |
Advent International LLC
Advent International LLC Investment ManagersFinance Advent International LLC provides risk capital and investments. The company is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jean-Pierre Garnier
Unternehmen | Position | Ende |
---|---|---|
CARMAT | Vorsitzender | 22.12.2022 |
RADIUS HEALTH, INC. | Direktor/Vorstandsmitglied | 15.08.2022 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Vorsitzender | 13.05.2020 |
IDORSIA LTD | Vorsitzender | 13.05.2020 |
░░░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Jean-Pierre Garnier
Stanford University | Masters Business Admin |
Louis Pasteur University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 8 |
---|---|
RENAULT | Consumer Durables |
GSK PLC | Health Technology |
ABIONYX PHARMA | Health Technology |
IDORSIA LTD | Health Technology |
CARMAT | Health Technology |
CARRIER GLOBAL CORPORATION | Producer Manufacturing |
CELLECTIS S.A. | Health Technology |
BIOAGE LABS, INC. | Health Technology |
Private Unternehmen | 17 |
---|---|
United Technologies Corp.
United Technologies Corp. Industrial ConglomeratesProducer Manufacturing United Technologies Corp. engages in the provision of products and services to the building systems and aerospace industries worldwide. It operates through the following business segments: Otis; Carrier; Pratt and Whitney; and Collins Aerospace Systems. The Otis segment designs, manufactures, sells, and installs elevators, escalators, moving walkways, and service. The Carrier segment provides heating, ventilating, air conditioning, and refrigeration solutions. The Pratt and Whitney segment includes aircraft engines for the commercial, military, business jet, and general aviation markets. The Collins Aerospace Systems segment offers technologically advanced aerospace products and aftermarket service solutions for aircraft manufacturers, airlines, regional, business and general aviation markets, military, space and undersea operations. The company was founded in 1934 and is headquartered in Farmington, CT. | Producer Manufacturing |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
e.Nvizion Communications Group Ltd. | Finance |
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Health Technology |
Pierre Fabre SA
Pierre Fabre SA BiotechnologyHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Health Technology |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | Health Technology |
Newman's Own Foundation
Newman's Own Foundation Investment Trusts/Mutual FundsMiscellaneous Newman's Own Foundation operates as a charity. The firm turns profits from the sale of Newman''s Own products into charitable donations. The company was founded by Paul L. Newman in 2005 and is headquartered in Farmington, CT. | Miscellaneous |
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Pierre Fabre Participations SAS
Pierre Fabre Participations SAS Pharmaceuticals: MajorHealth Technology Pierre Fabre Participations SASU operates as a holding company, with interests in the manufacture of pharmaceutical products. The company is headquartered in Paris, France. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Alzheon, Inc.
Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |
Max Planck Florida Institute for Neuroscience
Max Planck Florida Institute for Neuroscience Miscellaneous Commercial ServicesCommercial Services Max Planck Florida Institute for Neuroscience provides research services. It offers its services for neurobiology, brain function, neural circuits, neurological disorders, synaptic networks and bio-imaging. The company was founded in 2008 and is headquartered in Jupiter, FL. | Commercial Services |
Advent International LLC
Advent International LLC Investment ManagersFinance Advent International LLC provides risk capital and investments. The company is headquartered in Boston, MA. | Finance |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Health Technology |
Carrier Corp.
Carrier Corp. Industrial MachineryProducer Manufacturing Carrier Corp. manufactures air conditioning, heating, and refrigeration equipment. Its products include residential systems, commercial systems, transport refrigeration, and commercial refrigeration. The company was founded by Willis Haviland Carrier on July 17, 1902 and is headquartered in Jupiter, FL. | Producer Manufacturing |